8 May 2013 - Deborah Wilkes
Archived
All medicines containing domperidone – the active ingredient in Johnson & Johnson's Motilium – will be reverse-switched from non-prescription to prescription-only status in Belgium later this year.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.